Intragenic antagonistic roles of protein and circRNA in tumorigenesis
circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the Zbtb7a gene (also kown as POKEMON , LRF ) in the context of mesenchymal tumor progression. circPOK functions as a non-c...
Saved in:
Published in | Cell research Vol. 29; no. 8; pp. 628 - 640 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.08.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1001-0602 1748-7838 1748-7838 |
DOI | 10.1038/s41422-019-0192-1 |
Cover
Summary: | circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the
Zbtb7a
gene (also kown as
POKEMON
,
LRF
) in the context of mesenchymal tumor progression. circPOK functions as a non-coding proto-oncogenic RNA independently and antithetically to its linear transcript counterpart, which acts as a tumor suppressor by encoding the Pokemon transcription factor. We find that circPOK regulates pro-proliferative and pro-angiogenic factors by co-activation of the ILF2/3 complex. Importantly, the expression of Pokemon protein and circRNA is aberrantly uncoupled in cancer through differential post-transcriptional regulation. Thus, we identify a novel type of genetic unit, the iRegulon, that yields biochemically distinct RNA products, circular and linear, with diverse and antithetical functions. Our findings further expand the cellular repertoire towards the control of normal biological outputs, while aberrant expression of such components may underlie disease pathogenesis including cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1001-0602 1748-7838 1748-7838 |
DOI: | 10.1038/s41422-019-0192-1 |